The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review

9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The balance between ubiquitination and deubiquitination is critical for the degradation, transport, localization, and activity of proteins. Deubiquitinating enzymes (DUBs) greatly contribute to the balance of ubiquitination and deubiquitination, and they have been widely studied due to their fundamental role in cancer. DUB3/ubiquitin-specific protease 17 (USP17) is a type of DUB that has attracted much attention in cancer research. In this review, we summarize the biological functions and regulatory mechanisms of USP17 in central nervous system, head and neck, thoracic, breast, gastrointestinal, genitourinary, and gynecologic cancers as well as bone and soft tissue sarcomas, and we provide new insights into how USP17 can be used in the management of cancer.

Cite

CITATION STYLE

APA

Yang, G. F., Zhang, X., Su, Y. G., Zhao, R., & Wang, Y. Y. (2021, December 1). The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review. Cancer Cell International. BioMed Central Ltd. https://doi.org/10.1186/s12935-021-02160-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free